The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Moderate mutation rate in the SARS coronavirus genome and its implications
Open accessAbstract
BACKGROUND: The outbreak of severe acute respiratory syndrome (SARS) caused a severe global epidemic in 2003 which led to hundreds of deaths and many thousands of hospitalizations. The virus causing SARS was identified as a novel coronavirus (SARS-CoV) and multiple genomic sequences have been revealed since mid-April, 2003. After a quiet summer and fall in 2003, the newly emerged SARS cases in Asia, particularly the latest cases in China, are reinforcing a wide-spread belief that the SARS epidemic would strike back. With the understanding that SARS-CoV might be with humans for years to come, knowledge of the evolutionary mechanism of the SARS-CoV, including its mutation rate and emergence time, is fundamental to battle this deadly pathogen. To date, the speed at which the deadly virus evolved in nature and the elapsed time before it was transmitted to humans remains poorly understood. RESULTS: Sixteen complete genomic sequences with available clinical histories during the SARS outbreak were analyzed. After careful examination of multiple-sequence alignment, 114 single nucleotide variations were identified. To minimize the effects of sequencing errors and additional mutations during the cell culture, three strategies were applied to estimate the mutation rate by 1) using the closely related sequences as background controls; 2) adjusting the divergence time for cell culture; or 3) using the common variants only. The mutation rate in the SARS-CoV genome was estimated to be 0.80 - 2.38 x 10-3 nucleotide substitution per site per year which is in the same order of magnitude as other RNA viruses. The non-synonymous and synonymous substitution rates were estimated to be 1.16 - 3.30 x 10-3 and 1.67 - 4.67 x 10-3 per site per year, respectively. The most recent common ancestor of the 16 sequences was inferred to be present as early as the spring of 2002. CONCLUSIONS: The estimated mutation rates in the SARS-CoV using multiple strategies were not unusual among coronaviruses and moderate compared to those in other RNA viruses. All estimates of mutation rates led to the inference that the SARS-CoV could have been with humans in the spring of 2002 without causing a severe epidemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For the SARS-CoV-2 genome, the nonsynonymous to synonymous substitutions ratio is 0.028, indicating strong purifying selection [32].”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The neighbor-joining method: a new method for reconstructing phylogenetic trees.
Saitou, N., & Nei, M. (1987) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040454 · Cited by 59,959
Thompson, J. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.24.4876 · Cited by 38,685
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Evolution of Protein Molecules
JUKES, T. H., & CANTOR, C. R. (1969) · Mammalian Protein Metabolism · doi:10.1016/b978-1-4832-3211-9.50009-7 · Cited by 11,032
MEGA2: molecular evolutionary genetics analysis software
Kumar, S., Tamura, K., Jakobsen, I. B., & Nei, M. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.12.1244 · Cited by 6,046
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353
(1964) · Elsevier eBooks · doi:10.1016/b978-1-4832-3210-2.50006-6 · Cited by 3,130
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R. P., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,477
Guan, Y., Zheng, B., He, Y., Liu, X. L., Zhuang, Z. X., Cheung, C. L., Luo, S., Li, P. H., Zhang, L., Guan, Y., et al. (2003) · Science · doi:10.1126/science.1087139 · Cited by 2,404
The Genome Sequence of the SARS-Associated Coronavirus
Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A. R., Butterfield, Y. S. N., Khattra, J. S., Asano, J. K., Barber, S., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,027
Research works printed but not linked: 1
- Lai MC, Holmes KV: In: Knipe DM, Howley, PM, eds. Fundamental Virology. 2001, Lippincott, PA, Williams & Wilkins, 4
Cited by
Sorted by citations
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,729
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C.-K., Zhou, J., Liu, W., Bi, Y., & Gao, G. F. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.03.003 · Cited by 2,956
On the origin and continuing evolution of SARS-CoV-2
Tang, X., Wu, C., Li, X., Song, Y., Yao, X., Wu, X., Duan, Y., Zhang, H., Wang, Y., Qian, Z., et al. (2020) · National Science Review · doi:10.1093/nsr/nwaa036 · Cited by 1,627
Self-citationThe deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China
Yang, Y., Peng, F., Wang, R., Guan, K., Jiang, T., Xu, G., Sun, J., & Chang, C. C.-C. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102434 · Cited by 1,105
Zoonotic origins of human coronaviruses
Ye, Z., Yuan, S., Yuen, K., Fung, S., Chan, C., & Jin, D. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45472 · Cited by 967
Coronavirus Genomics and Bioinformatics Analysis
Woo, P. C. Y., Huang, Y., Lau, S. K. P., & Yuen, K. (2010) · Viruses · doi:10.3390/v2081803 · Cited by 919
Evolution and epidemic spread of SARS-CoV-2 in Brazil
Candido, D. S., Claro, I. M., de Jesus, J. G., Souza, W. M., Moreira, F. R. R., Dellicour, S., Mellan, T. A., du Plessis, L., Pereira, R. H. M., Sales, F. C. S., et al. (2020) · Science · doi:10.1126/science.abd2161 · Cited by 573
Variant analysis of SARS-CoV-2 genomes
Koyama, T., Platt, D. E., & Parida, L. (2020) · Bulletin of the World Health Organization · doi:10.2471/blt.20.253591 · Cited by 527
Shen, Z., Xiao, Y., Kang, L., Ma, W., Shi, L., Zhang, L., Zhou, Z., Yang, J., Zhong, J., Yang, D., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa203 · Cited by 513
Self-citationEvolutionary history, potential intermediate animal host, and cross‐species analyses of SARS‐CoV‐2
Li, X., Zai, J., Zhao, Q., Nie, Q. H., Li, Y., Foley, B. T., & Chaillon, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25731 · Cited by 428
A review of studies on animal reservoirs of the SARS coronavirus
Shi, Z., & Hu, Z. (2008) · Virus Research · doi:10.1016/j.virusres.2007.03.012 · Cited by 400
Fung, S., Yuen, K., Ye, Z., Chan, C., & Jin, D. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1736644 · Cited by 389
Transmission dynamics and evolutionary history of 2019‐nCoV
Li, X., Wang, W., Zhao, X., Zai, J., Zhao, Q., Li, Y., & Chaillon, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25701 · Cited by 316
No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2
van Dorp, L., Richard, D., Tan, C. C. S., Shaw, L. P., Acman, M., & Balloux, F. (2020) · Nature Communications · doi:10.1038/s41467-020-19818-2 · Cited by 311
On the origin and evolution of SARS-CoV-2
Singh, D., & Yi, S. V. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00604-z · Cited by 281
Hon, C.-C., Lam, T. T., Shi, Z., Drummond, A. J., Yip, C.-W., Zeng, F., Lam, P.-Y., & Leung, F. C.-C. (2007) · Journal of Virology · doi:10.1128/jvi.01926-07 · Cited by 217
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
Linsky, T. W., Vergara, R., Codina, N., Nelson, J. W., Walker, M. J., Su, W., Barnes, C. O., Hsiang, T.-Y., Esser-Nobis, K., Yu, K., et al. (2020) · Science · doi:10.1126/science.abe0075 · Cited by 216
Evidence for SARS-CoV-2 Infection of Animal Hosts
Abdel-Moneim, A. S., & Abdelwhab, E. M. (2020) · Pathogens · doi:10.3390/pathogens9070529 · Cited by 209
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Thakur, V., Bhola, S., Thakur, P., Patel, S. K. S., Kulshrestha, S., Ratho, R. K., & Kumar, P. (2022) · Infection · doi:10.1007/s15010-021-01734-2 · Cited by 195
“028, indicating strong purifying selection [32].”
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
Dearlove, B. L., Lewitus, É., Bai, H., Li, Y., Reeves, D. B., Joyce, M. G., Scott, P. T., Amare, M. F., Vasan, S., Michael, N. L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008281117 · Cited by 206
When are pathogen genome sequences informative of transmission events?
Campbell, F., Strang, C., Ferguson, N., Cori, A., & Jombart, T. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1006885 · Cited by 199
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
McLean, G. R., Kamil, J. P., Lee, B., Moore, P. L., Schulz, T. F., Muik, A., Şahin, U., Türeci, Ö., & Pather, S. (2022) · mBio · doi:10.1128/mbio.02979-21 · Cited by 195
Bioinformatic mapping of AlkB homology domains in viruses
Bratlie, M. S., & Drabløs, F. (2005) · BMC Genomics · doi:10.1186/1471-2164-6-1 · Cited by 186
Rahimi, A., Mirzazadeh, A., & Tavakolpour, S. (2020) · Genomics · doi:10.1016/j.ygeno.2020.09.059 · Cited by 180
Potential of large “first generation” human‐to‐human transmission of 2019‐nCoV
Li, X., Zai, J., Wang, X., & Li, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25693 · Cited by 169
On the Causes of Evolutionary Transition:Transversion Bias
Stoltzfus, A., & Norris, R. W. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv274 · Cited by 172
Yu, W.-B., Tang, G.-D., Zhang, L., & Corlett, R. T. (2020) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2020.022 · Cited by 157
Full-Genome Deep Sequencing and Phylogenetic Analysis of Novel Human Betacoronavirus
Cotten, M. L., Lam, T. T., Watson, S. J., Palser, A. L., Petrova, V. N., Grant, P. R., Pybus, O. G., Rambaut, A., Guan, Y., Pillay, D., et al. (2013) · Emerging infectious diseases · doi:10.3201/eid1905.130057 · Cited by 150
Evolutionary dynamics of SARS‐CoV‐2 nucleocapsid protein and its consequences
Rahman, M. S., Islam, M. R., Alam, A. S. M. R. U., Islam, I., Hoque, M. N., Akter, S., Rahaman, M. M., Sultana, M., & Hossain, M. A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26626 · Cited by 142
McKinley, E. T., Hilt, D. A., & Jackwood, M. W. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.01.006 · Cited by 136
Velázquez-Salinas, L., Zárate, S., Eberl, S., Gladue, D. P., Novella, I. S., & Borca, M. V. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.550674 · Cited by 135
Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients
Wang, Y., Wang, D., Zhang, L., Sun, W., Zhang, Z., Chen, W., Zhu, A., Huang, Y., Xiao, F., Yao, J., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00847-5 · Cited by 124
Self-citationSchmid‐Hempel, P. (2021) · doi:10.1093/oso/9780198832140.001.0001 · Cited by 137
Air transportation, population density and temperature predict the spread of COVID-19 in Brazil
Pequeno, P. A. C. L., Mendel, B., Rosa, C., Bosholn, M., Souza, J. L. P., Baccaro, F. B., Barbosa, R. I., & Magnusson, W. E. (2020) · PeerJ · doi:10.7717/peerj.9322 · Cited by 128
Presence of mismatches between diagnostic PCR assays and coronavirus SARS-CoV-2 genome
Khan, K. A., & Cheung, P. (2020) · Royal Society Open Science · doi:10.1098/rsos.200636 · Cited by 112
SARS-CoV-2 Vaccine Development: Current Status
Poland, G. A., Ovsyannikova, I. G., Crooke, S. N., & Kennedy, R. B. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.07.021 · Cited by 119
Kaur, N., Singh, R., Dar, Z., Bijarnia, R. K., Dhingra, N., & Kaur, T. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104490 · Cited by 115
Teruel, N., Mailhot, O., & Najmanovich, R. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009286 · Cited by 99
Sonnleitner, S. T., Prelog, M., Sonnleitner, S., Hinterbichler, E., Halbfurter, H., Kopecky, D. B. C., Almanzar, G., Koblmüller, S., Sturmbauer, C., Feist, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30163-4 · Cited by 107
Direct RNA sequencing and early evolution of SARS-CoV-2Preprint
Taiaroa, G., Rawlinson, D., Featherstone, L. A., Pitt, M. E., Caly, L., Druce, J. D., Purcell, D. F. J., Harty, L., Tran, T., Roberts, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.05.976167 · Cited by 101
Nussenblatt, V. R., Roder, A. E., Das, S. B., de Wit, E., Youn, J.-H., Banakis, S., Mushegian, A. A., Mederos, C., Wang, W., Chung, M. C., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab622 · Cited by 97
No evidence for distinct types in the evolution of SARS-CoV-2
MacLean, O. A., Orton, R. J., Singer, J. B., & Robertson, D. L. (2020) · Virus Evolution · doi:10.1093/ve/veaa034 · Cited by 96
SARS-Cov-2 ORF3a: Mutability and function
Bianchi, M., Borsetti, A., Ciccozzi, M., & Pascarella, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.142 · Cited by 95
Matyášek, R., & Kovařík, A. (2020) · Genes · doi:10.3390/genes11070761 · Cited by 78
Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
Egeren, D. V., Novokhodko, A., Stoddard, M., Tran, U., Zetter, B. R., Rogers, M. S., Pentelute, B. L., Carlson, J. M., Hixon, M. S., Joseph‐McCarthy, D., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250780 · Cited by 91
Distant residues modulate conformational opening in SARS-CoV-2 spike protein
Ray, D., Le, L., & Andricioaei, I. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100943118 · Cited by 89
Anand, U., Jakhmola, S., Indari, O., Jha, H. C., Chen, Z., Tripathi, V. S., & de la Lastra, J. M. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658519 · Cited by 84
A Founder Effect Led Early SARS-CoV-2 Transmission in Spain
Díez‐Fuertes, F., Iglesias‐Caballero, M., García‐Pérez, J., Monzón, S., Jiménez, P., Varona, S., Cuesta, I., Zaballos, Á., Jiménez, M., Checa, L., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01583-20 · Cited by 79
Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2Preprint
Su, Y. C. F., Anderson, D. E., Young, B. E., Zhu, F., Linster, M., Kalimuddin, S., Low, J. G. H., Zhuang, Y., Jayakumar, J., Sun, L. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.11.987222 · Cited by 73
SARS-CoV-2 reinfection and implications for vaccine development
Nainu, F., Abidin, R. S., Bahar, M. A., Frediansyah, A., Emran, T. B., Rabaan, A. A., Dhama, K., & Harapan, H. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1830683 · Cited by 73
Zhang, C.-Y., Wei, J., & He, S. (2006) · BMC Microbiology · doi:10.1186/1471-2180-6-88 · Cited by 70
Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2
Liu, S., Shen, J., Fang, S., Li, K., Liu, J., Yang, L., Hu, C., & Wan, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.593548 · Cited by 63
Campbell, F., Cori, A., Ferguson, N. M., & Jombart, T. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006930 · Cited by 72
COVID-19: is there a role for immunonutrition, particularly in the over 65s?
Derbyshire, E. J., & Delange, J. (2020) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2020-000071 · Cited by 63
The global population of SARS-CoV-2 is composed of six major subtypes
Morais, I. J., Polveiro, R. C., Souza, G. M., Bortolin, D. I., Sassaki, F. T., & Lima, A. T. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-74050-8 · Cited by 62
Amodio, E., Vitale, F. M., Cimino, L., Casuccio, A., & Tramuto, F. (2020) · Healthcare · doi:10.3390/healthcare8010051 · Cited by 58
Li, Y., Yang, X., Wang, N., Wang, H., Yin, B., Yang, X., & Jiang, W. (2020) · Future Virology · doi:10.2217/fvl-2020-0066 · Cited by 58
Subudhi, S., Rapin, N., Bollinger, T. K., Hill, J. E., Donaldson, M. E., Davy, C. M., Warnecke, L., Turner, J. M., Kyle, C. J., Willis, C. K. R., et al. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000898 · Cited by 56
Moubarak, M., Kasozi, K. I., Hetta, . F., Shaheen, H. M., Rauf, A., Al-Kuraishy, H. M., Qusti, S. Y., Alshammari, E. M., Ayikobua, E. T., Ssempijja, F., et al. (2021) · Life · doi:10.3390/life11080734 · Cited by 57
Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence?
Rödel, F., Arenas, M., Ott, O. J., Fournier, C., Georgakilas, A. G., Tapio, S., Trott, K.-R., & Gaipl, U. S. (2020) · Strahlentherapie und Onkologie · doi:10.1007/s00066-020-01635-7 · Cited by 53
Differential stepwise evolution of SARS coronavirus functional proteins in different host species
Tang, X., Li, G., Vasilakis, N., Zhang, Y., Shi, Z., Zhong, Y., Wang, L., & Zhang, S. (2009) · BMC Evolutionary Biology · doi:10.1186/1471-2148-9-52 · Cited by 50
Self-citationGenome evolution of SARS-CoV-2 and its virological characteristics
Nakagawa, S., & Miyazawa, T. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00126-7 · Cited by 52
Fan, W.-S., Tang, N., Dong, Z., Chen, J., Zhang, W., Zhao, C., He, Y., Li, M., Wu, C., Wei, T., et al. (2019) · Viruses · doi:10.3390/v11100898 · Cited by 50
Dai, Y., Wang, J., Jeong, H.-H., Chen, W., Jia, P., & Zhao, Z. (2021) · Human Genetics · doi:10.1007/s00439-021-02305-z · Cited by 49
Self-citationLlanes, A., Restrepo, C. M., Zuleima Caballero, E., Rajeev, S., Kennedy, M. A., & Lleonart, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124546 · Cited by 52
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Hoteit, R., & Yassine, H. M. (2022) · Vaccines · doi:10.3390/vaccines10060919 · Cited by 47
Bauer, D. C., Tay, A. P., Wilson, L. O. W., Reti, D., Hosking, C., McAuley, A. J., Pharo, E. A., Todd, S., Stevens, V., Neave, M. J., et al. (2020) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13588 · Cited by 46
Causes and Consequences of Purifying Selection on SARS-CoV-2
Castillo-Morales, A., Rice, A. M., Ho, A. T., Mordstein, C., Mühlhausen, S., Watson, S., Cano, L., Young, B., Kudla, G., & Hurst, L. D. (2021) · Genome Biology and Evolution · doi:10.1093/gbe/evab196 · Cited by 43
Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
Reuken, P. A., Stallmach, A., Pletz, M. W., Brandt, C., Andreas, N., Hahnfeld, S., Löffler, B., Baumgart, S., Kamradt, T., & Bauer, M. W. (2021) · Leukemia · doi:10.1038/s41375-021-01175-8 · Cited by 44
Dry Heat as a Decontamination Method for N95 Respirator Reuse
Oh, C., Araud, E., Puthussery, J. V., Bai, H., Clark, G. G., Wang, L., Verma, V., & Nguyen, T. H. (2020) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.0c00534 · Cited by 43
Phylogenetic perspectives on the epidemiology and origins of SARS and SARS-like coronaviruses
Yip, C. W., Hon, C.-C., Shī, M., Lam, T. T., Chow, K. Y. C., Zeng, F., & Leung, F. C.-C. (2009) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2009.09.015 · Cited by 43
GC usage of SARS-CoV-2 genes might adapt to the environment of human lung expressed genes
Li, Y., Yang, X., Wang, N., Wang, H., Yin, B., Yang, X., & Jiang, W. (2020) · Molecular Genetics and Genomics · doi:10.1007/s00438-020-01719-0 · Cited by 41
Das, J. K., & Roy, S. (2021) · Genomics · doi:10.1016/j.ygeno.2021.05.008 · Cited by 38
Gas Plasma Technology—An Asset to Healthcare During Viral Pandemics Such as the COVID-19 Crisis?
Bekeschus, S., Krämer, A., Suffredini, E., von Woedtke, T., & Colombo, V. (2020) · IEEE Transactions on Radiation and Plasma Medical Sciences · doi:10.1109/trpms.2020.3002658 · Cited by 39
Bai, Y., Jiang, D., Lon, J. R., Chen, X., Hu, M., Lin, S., Chen, Z., Wang, X., Meng, Y., & Du, H. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.08.066 · Cited by 40
Liu, T., Jia, P., Fang, B., & Zhao, Z. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.603509 · Cited by 38
Self-citationXiong, P., Zeng, X., Song, M., Jia, S., Zhong, M. H., Xiao, L., Lan, W., Cai, C., Wu, X., Gong, F., et al. (2008) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2007.00741.x · Cited by 37
Self-citationMarkers Associated with COVID-19 Susceptibility, Resistance, and Severity
Fakhroo, A. D., Thani, A. A. A., & Yassine, H. M. (2020) · Viruses · doi:10.3390/v13010045 · Cited by 38
Chakrabartty, I., Khan, M., Mahanta, S., Chopra, H., Dhawan, M. K., Choudhary, O. P., Bibi, S., Mohanta, Y. K., & Emran, T. B. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103985 · Cited by 38
Comparative Genomics Reveals Early Emergence and Biased Spatiotemporal Distribution of SARS-CoV-2
Chiara, M., Horner, D. S., Gissi, C., & Pesole, G. (2021) · Molecular Biology and Evolution · doi:10.1093/molbev/msab049 · Cited by 37
SARS-CoV-2 is well adapted for humans. What does this mean for re-emergence?Preprint
Zhan, S. H., Deverman, B. E., & Chan, Y. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.01.073262 · Cited by 34
Molecular Determinants of SARS-CoV-2 Variants
Banerjee, A., Mossman, K. L., & Grandvaux, N. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.07.002 · Cited by 34
Bats and viruses: a death-defying friendship
Gupta, P., Singh, M. P., Goyal, K., Tripti, P., Ansari, M. I., Rajendran, V. O., Dhama, K., & Malik, Y. S. (2021) · VirusDisease · doi:10.1007/s13337-021-00716-0 · Cited by 33
Coronavirus genomes carry the signatures of their habitats
Wei, Y., Silke, J. R., Aris, P., & Xia, X. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244025 · Cited by 31
Domingo‐Calap, P., Schubert, B., Joly, M., Solis, M., Untrau, M., Carapito, R., Georgel, P., Caillard, S., Fafi‐Kremer, S., Paul, N., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007368 · Cited by 30
Phylogenetic analysis of SARS‐CoV‐2 in the first few months since its emergence
Pereson, M. J., Mojsiejczuk, L. N., Martínez, A. P., Flichman, D., Garcia, G. H., & Lello, F. A. D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26545 · Cited by 29
Phylodynamics of SARS-CoV-2 transmission in SpainPreprint
Díez‐Fuertes, F., Iglesias‐Caballero, M., Monzón, S., Jiménez, P., Varona, S., Cuesta, I., Zaballos, Á., Thomson, M. M., Jiménez, M., García‐Pérez, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.20.050039 · Cited by 29
Identification of mutations in SARS-CoV-2 PCR primer regions
Mentes, A., Papp, K., Visontai, D., Stéger, J., VEO Technical Working Group, Csabai, I., Papp, K., Visontai, D., Stéger, J., Cochrane, G., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-21953-3 · Cited by 28
Al-Hatamleh, M. A. I., Hatmal, M. M., Alshaer, W., Rahman, E. N. S. E. A., Mohd-Zahid, M. H., Alhaj-Qasem, D. M., Yean, C. Y., Alias, I. Z., Jaafar, J., Ferji, K., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173930 · Cited by 28
Evolution, Ecology, and Zoonotic Transmission of Betacoronaviruses: A Review
Jelinek, H. F., Mousa, M., Alefishat, E. A., Osman, W. M., Spence, I., Bu, D., Feng, S. F., Byrd, J. H., Magni, P. A., Sahibzada, S., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.644414 · Cited by 28
Analysis of SARS-CoV-2 genome evolutionary patterns
Gupta, S., Gupta, D., & Bhatnagar, S. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.02654-23 · Cited by 29
Genetic drift in the genome of SARS COV‐2 and its global health concern
Bano, I., Sharif, M., & Alam, S. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27337 · Cited by 23
Gand, M., Vanneste, K., Thomas, I., Gucht, S. V., Capron, A., Herman, P., Roosens, N. H. C., & Keersmaecker, S. C. J. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155585 · Cited by 25
Mishra, A., Pandey, A. K., Gupta, P., Pradhan, P. C., Dhamija, S., Gomes, J., Kundu, B., Vivekanandan, P., & Menon, M. B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.07.082768 · Cited by 24
Imposed mutational meltdown as an antiviral strategy
Jensen, J. D., Stikeleather, R., Kowalik, T. F., & Lynch, M. (2020) · Evolution · doi:10.1111/evo.14107 · Cited by 21
The Effectiveness of Photobiomudulation therapy (PBMT) in COVID-19 Infection
Sherafat, S. J., Razaghi, Z., Rostami‐Nejad, M., Rezaei–Tavirani, M., & Razzaghi, M. (2020) · Journal of lasers in medical sciences · doi:10.34172/jlms.2020.s4 · Cited by 23
Population Genomics Insights into the First Wave of COVID-19
Vasilarou, M., Alachiotis, N., Garefalaki, J., Beloukas, A. I., & Pavlidis, P. (2021) · Life · doi:10.3390/life11020129 · Cited by 30
Akaishi, T. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00716-22 · Cited by 22
Li, Y., He, X., Li, M., Li, B., Yang, M., Xie, Y., Zhang, Y., & Ma, X. (2020) · Virus Genes · doi:10.1007/s11262-020-01746-4 · Cited by 21
Self-citationGenomics and Evolution of the Nidovirales
Gorbalenya, A. E. (2014) · ASM Press eBooks · doi:10.1128/9781555815790.ch2 · Cited by 21
Metadata
- Authors
- Zhao, Z., Li, H., Wu, X., Zhong, Y., Zhang, K., Zhang, Y.-P., Boerwinkle, E., & Fu, Y.-X.
- Affiliations
- Virginia Commonwealth University (US)
- The University of Texas Health Science Center at Houston (US)
- Kunming Institute of Zoology (CN)
- Yunnan University (CN)
- Corresponding author
- Fu, Yun-Xin
- Venue
- BMC Evolutionary Biology
- Published
- 2004-06-28
- Volume
- 4
- Issue
- 1
- Pages
- 21-21
- ISSN
- 1471-2148 (ISSN-L)
- PMC
- PMC446188
- OpenAlex
- W2134250657
- Cited by
- 286
- References
- 38
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 10 · 2023: 9 · 2022: 30 · 2021: 93 · 2020: 112 · 2019: 2 · 2018: 4 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 1
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- BMC Evolutionary Biology (publishedVersion)
- PubMed Central (publishedVersion, other-oa)
- PubMed (publishedVersion)
- VCU Scholars Compass (Virginia Commonwealth University) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Virginia Commonwealth University
- Yunnan University
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- SARS-CoV, mutation rate, viral evolution, single nucleotide polymorphisms, divergence time estimation, most recent common ancestor, emergence timing, RNA viruses, SARS epidemic
- MeSH terms
- Genes, Viral, Phylogeny, Viral Structural Proteins, Mutagenesis, Genome, Viral, Coronavirus, Evolution, Molecular, Severe acute respiratory syndrome-related coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review